Enter Note Done
Go to previous page in this tab
Session
  • DDW
  • Taking a Deep Dive Into Eohilia, an Oral Therapeutic Option
  • Session Number: 13160
    Set Timezone

Type: Product Theater

Description: Join our discussion as we look at answering an unmet need in pediatric and adult patients with Eosinophilic Esophagitis (EoE) through an oral therapeutic option, EOHILIA (budesonide oral suspension). EOHILIA is a ready-to-use oral suspension that was designed specifically for EoE.
Supported by: Takeda Pharmaceuticals U.S.A., Inc.

Society
Presentation